HomeCompareRYIPX vs JNJ

RYIPX vs JNJ: Dividend Comparison 2026

RYIPX yields 0.86% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RYIPX wins by $869.00 in total portfolio value
10 years
RYIPX
RYIPX
● Live price
0.86%
Share price
$14.16
Annual div
$0.12
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$90.80
Full RYIPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RYIPX vs JNJ

📍 RYIPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRYIPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RYIPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RYIPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYIPX
Annual income on $10K today (after 15% tax)
$72.99/yr
After 10yr DRIP, annual income (after tax)
$77.18/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $626.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYIPX + JNJ for your $10,000?

RYIPX: 50%JNJ: 50%
100% JNJ50/50100% RYIPX
Portfolio after 10yr
$20.5K
Annual income
$459.29/yr
Blended yield
2.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RYIPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYIPX buys
0
JNJ buys
0
No recent congressional trades found for RYIPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRYIPXJNJ
Forward yield0.86%3.36%
Annual dividend / share$0.12$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.9K$20.0K
Annual income after 10y$90.80$827.78
Total dividends collected$885.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RYIPX vs JNJ ($10,000, DRIP)

YearRYIPX PortfolioRYIPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,786$85.88$10,676$355.77+$110.00RYIPX
2$11,627$86.56$11,407$389.39+$220.00RYIPX
3$12,529$87.21$12,198$426.53+$331.00RYIPX
4$13,493$87.83$13,056$467.62+$437.00RYIPX
5$14,526$88.40$13,987$513.12+$539.00RYIPX
6$15,632$88.94$14,998$563.56+$634.00RYIPX
7$16,816$89.45$16,098$619.52+$718.00RYIPX
8$18,083$89.93$17,295$681.69+$788.00RYIPX
9$19,439$90.38$18,599$750.82+$840.00RYIPX
10$20,891$90.80$20,022$827.78+$869.00RYIPX

RYIPX vs JNJ: Complete Analysis 2026

RYIPXStock

Normally, the fund invests at least 80% of its net assets in equity securities of such premier companies headquartered outside of the United States. At least 65% of these securities will be issued by small-cap companies, with stock market capitalizations up to $5 billion at the time of investment. Under normal market circumstances, at least 65% of the fund's net assets will be invested in equity securities of international companies headquartered in at least three different countries.

Full RYIPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RYIPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYIPX vs SCHDRYIPX vs JEPIRYIPX vs ORYIPX vs KORYIPX vs MAINRYIPX vs ABBVRYIPX vs MRKRYIPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.